Virilizer Antibody (Rabbit mAb) [D21H17]

製品コード:F8294

印刷

生物学的記述

Specificity Virilizer Antibody (Rabbit mAb) [D21H17] detects endogenous levels of total Virilizer protein.
Background Virilizer (VIR), also known as VIRMA (VIR-like m6A methyltransferase associated) in mammals, functions as an essential regulatory component of the N6-methyladenosine (m6A) methyltransferase complex alongside catalytic subunits METTL3 and METTL14, adaptor protein WTAP, and additional factors HAKAI and ZC3H13, directing site-specific RNA methylation that regulates splicing, polyadenylation, translation, and mRNA stability. The protein contains a putative transmembrane domain, a coiled-coil region, and PEST sequences suggestive of rapid protein turnover, with nuclear localization enabling direct participation in co-transcriptional mRNA modification events. Virilizer recruits the catalytic core components METTL3/METTL14/WTAP to specific mRNA regions, guiding preferential m6A methylation in 3' untranslated regions (3'UTR) and near stop codons rather than randomly distributing methylation across transcripts, with approximately 60% of VIRMA-bound mRNA targets exhibiting strong m6A enrichment in 3'UTR. The protein associates with polyadenylation cleavage factors CPSF5 and CPSF6 in an RNA-dependent manner, functionally linking m6A deposition to alternative polyadenylation (APA) regulation—depletion of VIRMA or METTL3 induces 3'UTR lengthening of several hundred mRNAs with over 50% overlapping targets, while CPSF5 depletion causes 3'UTR shortening of thousands of mRNAs that are predominantly m6A-modified. Virilizer executes critical developmental functions in Drosophila melanogaster sex determination by enabling female-specific splicing of Sex-lethal (Sxl) pre-mRNA, which serves as the master regulatory switch controlling somatic sexual differentiation, dosage compensation, and oogenesis. The female-specific Sxl splicing requires m6A modification within the sex-specifically spliced intron, with the m6A reader protein YT521-B decoding these methylation marks to facilitate proper splice site selection, and loss of virilizer function phenocopies Ime4 (the Drosophila METTL3 homolog) mutants by causing female-to-male sexual transformation and female-specific lethality. Virilizer-dependent m6A methylation potentiates Sxl autoregulatory splicing, wherein SXL protein maintains its own female-specific expression pattern through positive feedback, with virilizer mutations disrupting this autoregulation and causing production of male-specific Sxl and transformer (tra) splice variants even in XX animals. The protein functions throughout development with ubiquitous expression in male and female embryos, serving sex-specific roles in females while executing essential vital functions required for viability in both sexes. Maternal virilizer products deposited in eggs prove essential for early post-transcriptional Sxl regulation in XX embryos, establishing sex-specific gene expression programs before zygotic transcription initiates, and for undefined vital processes required in embryos of both sexes. Virilizer operates in germline sex determination, where early SXL production in undifferentiated germ cells proceeds independently of virilizer, but later oogenic SXL expression becomes virilizer-dependent, with virilizer-mutant XX germ cells capable of completing oogenesis despite lacking late SXL proteins. The m6A modification directed by virilizer affects alternative splicing predominantly in 5' untranslated regions beyond sex determination targets and exerts global effects on metabolic gene expression, positioning virilizer as a broad post-transcriptional regulator integrating developmental, metabolic, and sex-specific gene expression programs. The yeast homolog Vir1p interacts with all members of the yeast methyltransferase complex and proves essential for mRNA m6A methylation and successful completion of meiosis, demonstrating evolutionary conservation of virilizer function in gametogenesis and reproductive processes. Specific virilizer alleles exhibit differential functional impacts—truncating mutations affecting large protein regions cause lethality in both sexes, whereas missense mutations clustering within defined protein regions selectively disrupt female-specific functions while preserving vital activities.

使用情報

Application WB, IHC, IF Dilution
WB IP CHIP
1:1000 1:50 1:50
Reactivity Human, Mouse, Rat, Monkey
Source Rabbit Monoclonal Antibody MW 210 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 250 mA, 180 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 
IF
Experimental Protocol:
 
Sample Preparation
1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
 
Fixation
1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
2. Wash the sample with PBS for 3 times, 3 minutes each time.
 
Permeabilization
1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
(Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
Wash the sample with PBS for 3 times, 3 minutes each time.
 
Blocking
Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
 
Immunofluorescence Staining (Day 1)
1. Remove the blocking solution and add the diluted primary antibody.
2. Incubate the sample in a humidified chamber at 4°C overnight.
 
Immunofluorescence Staining (Day 2)
1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
5. Wash with PBST for 3 times, 5 minutes each time.
 
Mounting
1. Mount the sample with an anti-fade mounting medium.
2. Allow the slide to dry at room temperature overnight in the dark.
3. Store the slide in a slide storage box at 4°C, protected from light.
 

References

  • https://pubmed.ncbi.nlm.nih.gov/8575302/
  • https://pubmed.ncbi.nlm.nih.gov/29507755/

Application Data

WB

Validated by Selleck

  • F8294-wb.gif
    Lane 1: K562, Lane 2: C2C12, Lane 3: H-4-II-E, Lane 4: COS-7